NEUROCRINE BIOSCIENCES INC
NBIX
71 insider filings · Latest: Sep 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Jun 8 10:07 PM | Leslie V NorwalkDirector | Sale | 1,250 | $168.06 | $210.1K | 2,838(D) | View → |
| Jun 5, 2026 | Jun 5 8:31 PM | STEPHEN SHERWIN | Proposed Sale | 25,000 | $167.35 | $4.2M | — | View → |
| Jun 2, 2026 | Jun 4 10:02 PM | Julie CookeChief Human Resources Officer | Sale | 36,937 | $156.22 | $5.8M | 22,374(D) | View → |
| Jun 1, 2026 | Jun 2 10:08 PM | Jude OnyiaChief Scientific Officer | Sale | 11,000 | $160.25 | $1.8M | 25,846(D) | View → |
| May 29, 2026 | Jun 2 10:03 PM | Ingrid DelaetChief Regulatory Officer | Sale | 2,261 | $156.71 | $354.3K | 16,225(D) | View → |
| Jun 2, 2026 | Jun 2 8:39 PM | JULIE COOKE | Proposed Sale | 36,937 | $161.00 | $5.9M | — | View → |
| Jun 1, 2026 | Jun 1 8:25 PM | JUDE ONYIA | Proposed Sale | 11,000 | $158.30 | $1.7M | — | View → |
| May 27, 2026 | May 29 10:09 PM | Jude OnyiaChief Scientific Officer | Sale | 11,000 | $155.53 | $1.7M | 25,846(D) | View → |
| May 29, 2026 | May 29 8:25 PM | INGRID DELAET | Proposed Sale | 2,261 | $156.39 | $353.6K | — | View → |
| May 26, 2026 | May 28 10:08 PM | David W. BoyerChief Corp. Affairs Officer | Sale | 3,888 | $156.64 | $609.0K | 7,799(D) | View → |
| May 27, 2026 | May 27 8:33 PM | JUDE ONYIA | Proposed Sale | 11,000 | $155.73 | $1.7M | — | View → |
| May 26, 2026 | May 26 8:45 PM | DAVID WARREN BOYER | Proposed Sale | 3,888 | $156.70 | $609.2K | — | View → |
| May 19, 2026 | May 21 9:49 PM | Kevin Charles GormanDirector | Sale | 245,088 | $154.33 | $37.8M | 511,293(D) | View → |
| May 19, 2026 | May 19 8:31 PM | KEVIN CHARLES GORMAN | Proposed Sale | 245,088 | $157.21 | $38.5M | — | View → |
| May 15, 2026 | May 18 9:50 PM | POPS RICHARD FDirector | Sale | 15,000 | $157.65 | $2.4M | 34,480(D) | View → |
| May 15, 2026 | May 15 8:33 PM | RICHARD F POPS | Proposed Sale | 15,000 | $159.05 | $2.4M | — | View → |
| May 12, 2026 | May 14 8:45 PM | Leslie V NorwalkDirector | Sale | 3,810 | $155.01 | $590.6K | 2,429(D) | View → |
| May 12, 2026 | May 12 6:35 PM | Norwalk Leslie V | Proposed Sale | 6,310 | $162.92 | $1.0M | — | View → |
| Jan 16, 2026 | Jan 20 11:56 PM | Kyle GanoDirector, Chief Executive Officer | Sale | 36,400 | $132.70 | $4.8M | 140,407(D) | View → |
| Jan 16, 2026 | Jan 16 9:21 PM | KYLE GANO | Proposed Sale | 36,400 | $133.35 | $4.9M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Sep 11 12:29 AM | Eric BenevichChief Commercial Officer | Option Exercise | 3,194 | $43.24 | 0(D) | View → |
| Jul 29, 2026 | Jul 30 9:29 PM | Leslie V NorwalkDirector | Option Exercise | 842 | $139.43 | 2,140(D) | View → |
| Jul 10, 2026 | Jul 13 8:27 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 4,367 | $106.02 | 0(D) | View → |
| Jul 9, 2026 | Jul 13 8:27 PM | Darin LippoldtChief Legal Officer | Option Exercise | 10,000 | $81.49 | 4,965(D) | View → |
| Jul 9, 2026 | Jul 9 10:41 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 8,433 | $103.52 | 7,478(D) | View → |
| Jul 8, 2026 | Jul 9 10:41 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 2,737 | $103.52 | 15,911(D) | View → |
| Jul 7, 2026 | Jul 9 10:41 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 3,401 | $103.52 | 18,648(D) | View → |
| Jun 29, 2026 | Jun 30 8:52 PM | Darin LippoldtChief Legal Officer | Option Exercise | 9,800 | $81.49 | 14,965(D) | View → |
| Jun 26, 2026 | Jun 30 8:52 PM | Darin LippoldtChief Legal Officer | Option Exercise | 200 | $81.49 | 24,765(D) | View → |
| Jun 5, 2026 | Jun 9 9:40 PM | SHERWIN STEPHEN ADirector | Option Exercise | 25,000 | $79.79 | 0(D) | View → |
| Jun 2, 2026 | Jun 4 10:02 PM | Julie CookeChief Human Resources Officer | Option Exercise | 24,965 | $81.49 | 0(D) | View → |
| Jun 2, 2026 | Jun 4 9:54 PM | Sanjay Chandru KeswaniChief Medical Officer | Option Exercise | 3,212 | — | 9,634(D) | View → |
| Jun 1, 2026 | Jun 2 10:08 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 11,000 | $84.74 | 13,268(D) | View → |
| May 29, 2026 | Jun 2 10:03 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 2,261 | $79.02 | 0(D) | View → |
| May 27, 2026 | May 29 10:09 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 11,000 | $84.74 | 24,268(D) | View → |
| May 27, 2026 | May 29 10:05 PM | Kevin Charles GormanDirector | Grant/Award | 5,248 | $155.83 | 5,248(D) | View → |
| May 27, 2026 | May 29 10:05 PM | POPS RICHARD FDirector | Grant/Award | 2,567 | $0.00 | 2,567(D) | View → |
| May 27, 2026 | May 29 10:04 PM | LYONS GARY ADirector | Grant/Award | 3,908 | $155.83 | 2,624(D) | View → |
| May 27, 2026 | May 29 10:04 PM | Johanna MercierDirector | Grant/Award | 2,567 | $0.00 | 2,567(D) | View → |
| May 27, 2026 | May 29 10:03 PM | Christine A PoonDirector | Grant/Award | 2,567 | $0.00 | 2,567(D) | View → |
Page 1 of 4
Next →